CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,990 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03532932
NCT03532932N/ACompleted

International, Multicentre, Non-Interventional Study To Evaluate Disease Control And Treatment Pattern In Patients With Moderate To Severe Inflammatory Bowel Disease In Real Life Practice

Takeda·observational·Posted May 22, 2018·Updated Mar 29, 2024

In Brief

An observational study for Colitis, Ulcerative and 2 related conditions. Completed, enrolled 1,990 participants across 36 sites in 3 countries.

Detailed Summary

The purpose of this study is to characterize the treatment patterns associated with biologics agents use or non-biological therapy in participants with moderate to severe Ulcerative Colitis (UC) and Crohn's Disease (CD).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesBelarus, Kazakhstan, Russia
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 22, 2018
Enrollment StartJul 20, 2018
Primary CompletionNov 8, 2021
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 8.1 years ago